Pfizer Stock Rallies 2% on Metsera Acquisition and Q3 Earnings Beat: Obesity Pipeline Expansion Amid Dividend Hike
Pfizer Inc. (NYSE: PFE) shares rose 2% on November 10, 2025, closing at $24.81 after the pharmaceutical giant announced the $1.7 billion acquisition of Metsera Inc., a promising obesity drug developer, and reported a third-quarter 2025 earnings beat that highlighted […]










